The Objectives of This Study Are Study the Safety, Reactogenicity and Obtain Preliminary Data on the Immunogenicity of Flu-M Quadro, 4-valent Inactivated Split Influenza Vaccine, in Healthy Volunteers

NCT05152017 ↗

Phase 1 Completed 75 enrolled St. Petersburg Research Institute of Vaccines and Sera

RandomizedParallel-groupSingle-blindPrevention

Summary

The study the safety, reactogenicity and obtain preliminary data on the immunogenicity of Flu-M Quadro, 4-valent inactivated split influenza vaccine, in healthy volunteers

Timeline

Start: 2019-11-16
Primary completion: 2020-01-22
Completion: 2020-01-24

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Flu-M Quadro	Vaccine	0.5 ml	Intramuscular

The Objectives of This Study Are Study the Safety, Reactogenicity and Obtain Preliminary Data on the Immunogenicity of Flu-M Quadro, 4-valent Inactivated Split Influenza Vaccine, in Healthy Volunteers

Summary

Timeline

Drugs

Indications